Exploring effects of Souvenaid on cerebral glucose metabolism in Alzheimer's disease.

Alzheimers Dement (N Y) · 2019 · PMC6804721 · PMID 31650005

Europe PMC DOI

hedged sentence

0.0500

closest p · 1.0× alpha

0.0500

boldest claim

The sentences

reached borderline significanceP = .05actually significant

Only the semiquantitative delta value of the inferolateral remainder of the left parietal lobe reached borderline significance (−0.01 ± 0.04 in the intervention group vs. 0.02 ± 0.06 in the placebo group, P = .05).

also in 370 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.